benzoxazoles has been researched along with alpha-synuclein in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cappai, R; Fodero-Tavoletti, MT; Furumoto, S; Kudo, Y; Masters, CL; Mulligan, RS; Okamura, N; Rowe, CC; Villemagne, VL; Yanai, K | 1 |
| Arai, H; Baba, T; Fukuda, H; Funaki, Y; Furumoto, S; Hasegawa, T; Itoyama, Y; Iwata, R; Kikuchi, A; Kobayashi, M; Kudo, Y; Miki, Y; Mori, F; Okamura, N; Sugeno, N; Takahashi, S; Takeda, A; Tashiro, M; Wakabayashi, K; Yanai, K | 1 |
| Baron, T; Billard, T; Bouillot, C; Chauveau, F; Lancelot, S; Levigoureux, E; Verchere, J; Verdurand, M; Zimmer, L | 1 |
| Billard, T; Chauveau, F; Lancelot, S; Levigoureux, E; Perret-Liaudet, A; Quadrio, I; Verdurand, M; Zeinyeh, W; Zimmer, L | 1 |
| Andersen, CB; Christiansen, G; Giehm, L; Hirst, WD; Jessen, CM; Krishnamurthy, G; Kurnik, M; Lorenzen, N; Mente, S; Mohammad-Beigi, H; Mulder, FAA; Otzen, DE; Pedersen, JS; Petersen, SV; Pitts, K; Reinhart, PH; Sahin, C; Staal, R | 1 |
| Adam, GC; Burlein, C; Cosden, M; Drolet, RE; Flick, R; Fraley, M; Gretzula, CA; Hatcher, NG; Jinn, S; Kandebo, M; Lemaire, W; Ma, L; Marcus, JN; Minnick, C; Mulhearn, J; Smith, SM; Toolan, D; Watt, ML; Yao, L | 1 |
6 other study(ies) available for benzoxazoles and alpha-synuclein
| Article | Year |
|---|---|
In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Benzoxazoles; Brain; Fluorine Radioisotopes; Humans; Immunohistochemistry; Lewy Bodies; Lewy Body Disease; Peptide Fragments; Protein Binding; Substrate Specificity; Thiazoles | 2009 |
In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy.
Topics: alpha-Synuclein; Benzoxazoles; Brain; Carbon Radioisotopes; Female; Humans; Immunohistochemistry; Male; Microscopy, Fluorescence; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Thiazoles | 2010 |
Binding of the PET radiotracer [¹⁸F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice.
Topics: alpha-Synuclein; Animals; Benzoxazoles; Brain Stem; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Radioligand Assay; Tauopathies; Thalamus; Thiazoles | 2014 |
Amyloid-Beta Radiotracer [
Topics: Aged; alpha-Synuclein; Benzoxazoles; Brain; Female; Fluorine Radioisotopes; Humans; Immunohistochemistry; Male; Multiple System Atrophy; Neuroglia; Positron-Emission Tomography; Thiazoles | 2018 |
Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State.
Topics: alpha-Synuclein; Amyloid; Benzoxazoles; Fluorescence Resonance Energy Transfer; High-Throughput Screening Assays; Humans; Protein Aggregates; Protein Conformation; Protein Multimerization | 2018 |
A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
Topics: alpha-Synuclein; Animals; Benzoxazoles; Dopaminergic Neurons; Glucosylceramidase; Glucosyltransferases; Glycosphingolipids; In Vitro Techniques; Lysosomes; Mice; Neurons; Parkinson Disease; Primary Cell Culture; Protein Aggregates; Rats; Synucleinopathies | 2021 |